The Asia Pacific Intraoperative Imaging Market is expected to witness market growth of 6.8% CAGR during the forecast period (2022-2028).
In the healthcare industry across the world, creating intraoperative imaging devices with cutting-edge technology is crucial. To improve the results of surgery, major players are producing new intraoperative imaging technologies. For instance, the hospital organization Atrium Health announced in 2021 that the brain care centre is expected to incorporate intraoperative magnetic resonance imaging equipment. It is projected that the rising use of such new technologies among end users, such as hospitals and clinics, will present attractive prospects for the expansion of the intraoperative imaging market.
Additionally, a spike in the number of cancer surgeries helps the industry expand. This is explained by the fact because intraoperative imaging is utilized in various cancer operations to locate tumours precisely during surgery and identify tiny lesions, both of which are necessary for surgeons to build effective surgical plans. The surgeons' placement of implants in the patient's body is guided by the intraoperative imaging gadget.
The National Healthcare Policy, known as Healthy China 2030, has been adopted by the Chinese central government with the aim of enhancing the wellness of its populace. One of the primary tasks is to strengthen the hierarchical medical system throughout the nation. Plans for establishing and enhancing the capacity of medical institutes and clinical labs are part of this strategy. The need for ultrasound scans also rises with the implementation of a three-child policy. This is expected to also increase the need for various imaging devices like intraoperative imaging in the region.
The China market dominated the Asia Pacific Intraoperative Imaging Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $309.7 million by 2028. The Japan market is anticipated to grow at a CAGR of 6.1% during (2022 - 2028). Additionally, The India market is expected to showcase a CAGR of 7.4% during (2022 - 2028).
Based on End-use, the market is segmented into Hospital and Others. Based on Component, the market is segmented into System, Software, and Services. Based on Product, the market is segmented into C-arm System, Intraoperative CT, Intraoperative Ultrasound and Intraoperative MRI. Based on Application, the market is segmented into Neurosurgery, Orthopedic, ENT Surgery, Oncology Surgery, Trauma surgery/ emergency room, Cardiovascular and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co., Koninklijke Philips N.V., Medtronic PLC, Siemens Healthineers AG (Siemens AG), Stryker Corporation, Fujifilm Holdings Corporation, Carl Zeiss Meditec AG (Carl Zeiss AG), Brainlab AG, Carestream Health, Inc. (Onex Corporation) and Ziehm Imaging GmbH
In the healthcare industry across the world, creating intraoperative imaging devices with cutting-edge technology is crucial. To improve the results of surgery, major players are producing new intraoperative imaging technologies. For instance, the hospital organization Atrium Health announced in 2021 that the brain care centre is expected to incorporate intraoperative magnetic resonance imaging equipment. It is projected that the rising use of such new technologies among end users, such as hospitals and clinics, will present attractive prospects for the expansion of the intraoperative imaging market.
Additionally, a spike in the number of cancer surgeries helps the industry expand. This is explained by the fact because intraoperative imaging is utilized in various cancer operations to locate tumours precisely during surgery and identify tiny lesions, both of which are necessary for surgeons to build effective surgical plans. The surgeons' placement of implants in the patient's body is guided by the intraoperative imaging gadget.
The National Healthcare Policy, known as Healthy China 2030, has been adopted by the Chinese central government with the aim of enhancing the wellness of its populace. One of the primary tasks is to strengthen the hierarchical medical system throughout the nation. Plans for establishing and enhancing the capacity of medical institutes and clinical labs are part of this strategy. The need for ultrasound scans also rises with the implementation of a three-child policy. This is expected to also increase the need for various imaging devices like intraoperative imaging in the region.
The China market dominated the Asia Pacific Intraoperative Imaging Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $309.7 million by 2028. The Japan market is anticipated to grow at a CAGR of 6.1% during (2022 - 2028). Additionally, The India market is expected to showcase a CAGR of 7.4% during (2022 - 2028).
Based on End-use, the market is segmented into Hospital and Others. Based on Component, the market is segmented into System, Software, and Services. Based on Product, the market is segmented into C-arm System, Intraoperative CT, Intraoperative Ultrasound and Intraoperative MRI. Based on Application, the market is segmented into Neurosurgery, Orthopedic, ENT Surgery, Oncology Surgery, Trauma surgery/ emergency room, Cardiovascular and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co., Koninklijke Philips N.V., Medtronic PLC, Siemens Healthineers AG (Siemens AG), Stryker Corporation, Fujifilm Holdings Corporation, Carl Zeiss Meditec AG (Carl Zeiss AG), Brainlab AG, Carestream Health, Inc. (Onex Corporation) and Ziehm Imaging GmbH
Scope of the Study
Market Segments Covered in the Report:
By End-use- Hospital
- Others
- System
- Software
- Services
- C-arm System
- Intraoperative CT
- Intraoperative Ultrasound
- Intraoperative MRI
- Neurosurgery
- Orthopedic
- ENT Surgery
- Oncology Surgery
- Trauma surgery/ emergency room
- Cardiovascular
- Others
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- General Electric (GE) Co.
- Koninklijke Philips N.V.
- Medtronic PLC
- Siemens Healthineers AG (Siemens AG)
- Stryker Corporation
- Fujifilm Holdings Corporation
- Carl Zeiss Meditec AG (Carl Zeiss AG)
- Brainlab AG
- Carestream Health, Inc. (Onex Corporation)
- Ziehm Imaging GmbH
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Competition Analysis - Global
Chapter 4. Asia Pacific Intraoperative Imaging Market by End-use
Chapter 5. Asia Pacific Intraoperative Imaging Market by Component
Chapter 6. Asia Pacific Intraoperative Imaging Market by Product
Chapter 7. Asia Pacific Intraoperative Imaging Market by Application
Chapter 8. Asia Pacific Intraoperative Imaging Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- General Electric (GE) Co.
- Koninklijke Philips N.V.
- Medtronic PLC
- Siemens Healthineers AG (Siemens AG)
- Stryker Corporation
- Fujifilm Holdings Corporation
- Carl Zeiss Meditec AG (Carl Zeiss AG)
- Brainlab AG
- Carestream Health, Inc. (Onex Corporation)
- Ziehm Imaging GmbH
Methodology
LOADING...
